CPT® Code 80347

1. Indications

The laboratory test represented by CPT® Code 80347 is indicated for the detection and quantification of 13 or more benzodiazepines in various biological specimens. This test is particularly relevant in the following scenarios:

• Substance Abuse Evaluation This test may be performed to assess potential benzodiazepine abuse or misuse in patients, especially in cases where there is a history of substance use disorders.
• Monitoring Treatment It is utilized to monitor patients who are prescribed benzodiazepines for therapeutic purposes, ensuring adherence to prescribed regimens and identifying any unauthorized use of additional benzodiazepines.
• Assessment of Overdose The test can be critical in emergency situations where benzodiazepine overdose is suspected, aiding in the diagnosis and management of the patient’s condition.
• Legal and Forensic Testing This test may be requested in legal contexts, such as in cases of impaired driving or other legal matters where benzodiazepine use is relevant.

2. Procedure

The procedure for conducting the test associated with CPT® Code 80347 involves several key steps, each critical for accurate results:

• Sample Collection The first step in the procedure is the collection of biological specimens. A blood sample is obtained through venipuncture, which is a standard method for drawing blood. Urine can be collected either through random voiding or catheterization, depending on the clinical scenario. Additionally, meconium stool samples may be collected from a diaper, particularly in pediatric cases.
• Sample Preparation Once the samples are collected, they must be properly prepared for analysis. This involves ensuring that the specimens are stored and transported under appropriate conditions to maintain their integrity until testing can be performed.
• Analytical Testing The actual testing process varies based on the type of specimen. For serum, plasma, and meconium samples, quantitative liquid chromatography-tandem mass spectrometry (LC-MS/MS) is employed, which allows for precise measurement of the benzodiazepine levels. In contrast, urine samples are analyzed using quantitative high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS), which is also a highly sensitive and specific method for detecting benzodiazepines.
• Result Interpretation After the analysis is complete, the results are interpreted by qualified laboratory personnel. The findings will indicate the presence and concentration of 13 or more benzodiazepines, which can then be used to inform clinical decisions and patient management.

3. Post-Procedure

Post-procedure care following the collection of samples for CPT® Code 80347 is generally minimal, as the primary focus is on the analysis of the specimens. However, it is essential to ensure that patients are informed about the potential for results to indicate the presence of multiple benzodiazepines, which may necessitate further clinical evaluation or intervention. Patients should also be advised to follow up with their healthcare provider to discuss the results and any necessary next steps in their treatment or management plan. Additionally, if the test was conducted in an emergency setting, appropriate follow-up care should be arranged based on the clinical context and findings.